¿Cómo se comparó el EPS reciente de NUWE con las expectativas?
¿Cómo fue el desempeño de los ingresos de Nuwellis Inc NUWE en el último trimestre?
¿Cuál es la estimación de ingresos para Nuwellis Inc?
¿Cuál es la puntuación de calidad de ganancias de Nuwellis Inc?
¿Cuándo informa Nuwellis Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Nuwellis Inc?
¿Superó Nuwellis Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$2.21
Precio de apertura
$2.27
Rango del día
$2.12 - $2.31
Rango de 52 semanas
$1.71 - $62.16
Volumen
28.6K
Volumen promedio
2.1M
EPS (TTM)
-107.67
Rendimiento de dividendos
--
Cap. de mercado
$3.5M
¿Qué es NUWE?
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.